Triggering antibody-mediated innate immune mechanisms to kill cancer cells is an attractive therapeutic avenue. In this context, recruitment of endogenous antibodies to the cancer cell surface could be a viable alternative to the use of monoclonal antibodies. We report on antibody-recruiting polymers containing multiple antibody-binding hapten motifs and cyclooctynes that can covalently conjugate to azides introduced onto the glycocalyx of cancer cells by metabolic labeling with azido sugars
International audienceMetabolic glycoengineering with unnatural sugars became a valuable tool for in...
Monoclonal antibodies represent the most successful class of biopharmaceuticals for the treatment of...
The development of nanoengineered particles, such as polymersomes, liposomes, and polymer capsules, ...
Binding of monoclonal antibodies (mAbs) onto a cell surface triggers antibody-mediated effector kill...
Binding of monoclonal antibodies (mAbs) onto a cell surface triggers antibody-mediated effector kill...
Synthetic macromolecular chemotherapeutics inspired by host defence peptides can disrupt cell membra...
Lack of a universal site-specific conjugation methodology for antibodies limits their potential to b...
Installation of an antibody-recruiting moiety on the surface of disease-relevant cells can lead to t...
The routine approach for targeting nanoparticle delivery vehicles to cancer cells is by incorporatin...
Recruiting endogenous antibodies to the surface of cancer cells using antibody-recruiting molecules ...
Synthetic materials capable of engineering the immune system are of great relevance in the fight aga...
Stimulation of the body's immune system toward tumor cells is now well recognized as a promising str...
Biological ligands such as aptamer, antibody, glucose, and peptide have been widely used to bind spe...
International audienceWe have developed af ully synthetic and multi-functional antibody-recruiting m...
The present study investigated the potential of metabolic glycoengineering followed by bioorthogonal...
International audienceMetabolic glycoengineering with unnatural sugars became a valuable tool for in...
Monoclonal antibodies represent the most successful class of biopharmaceuticals for the treatment of...
The development of nanoengineered particles, such as polymersomes, liposomes, and polymer capsules, ...
Binding of monoclonal antibodies (mAbs) onto a cell surface triggers antibody-mediated effector kill...
Binding of monoclonal antibodies (mAbs) onto a cell surface triggers antibody-mediated effector kill...
Synthetic macromolecular chemotherapeutics inspired by host defence peptides can disrupt cell membra...
Lack of a universal site-specific conjugation methodology for antibodies limits their potential to b...
Installation of an antibody-recruiting moiety on the surface of disease-relevant cells can lead to t...
The routine approach for targeting nanoparticle delivery vehicles to cancer cells is by incorporatin...
Recruiting endogenous antibodies to the surface of cancer cells using antibody-recruiting molecules ...
Synthetic materials capable of engineering the immune system are of great relevance in the fight aga...
Stimulation of the body's immune system toward tumor cells is now well recognized as a promising str...
Biological ligands such as aptamer, antibody, glucose, and peptide have been widely used to bind spe...
International audienceWe have developed af ully synthetic and multi-functional antibody-recruiting m...
The present study investigated the potential of metabolic glycoengineering followed by bioorthogonal...
International audienceMetabolic glycoengineering with unnatural sugars became a valuable tool for in...
Monoclonal antibodies represent the most successful class of biopharmaceuticals for the treatment of...
The development of nanoengineered particles, such as polymersomes, liposomes, and polymer capsules, ...